Loading clinical trials...
Loading clinical trials...
This is a prospective study of the safety and efficacy of nivolumab for the treatment of relapsed or residual haematological malignancies after allogeneic stem cell transplantation (alloSCT). Eligibl...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Melbourne Health
NCT06510699 · Fungal Infection, Haematological Malignancy, and more
NCT04068597 · Haematological Malignancy, Acute Myeloid Leukemia, and more
NCT06814405 · Haematological Malignancy
NCT06787326 · Haematological Malignancy, Febrile Neutropenia, and more
NCT07440290 · Haematological Malignancy, Malignant Neoplasm, and more
Royal Melbourne Hospital
Parkville, Victoria
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions